Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 146 | 1.110 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 1044 | 0.980 |
Why?
|
| Cerebral Hemorrhage | 5 | 2022 | 100 | 0.810 |
Why?
|
| Brain Mapping | 6 | 2021 | 142 | 0.780 |
Why?
|
| Blood Glucose | 2 | 2020 | 101 | 0.780 |
Why?
|
| Biomarkers | 3 | 2020 | 517 | 0.690 |
Why?
|
| Neuregulins | 1 | 2019 | 1 | 0.650 |
Why?
|
| Headache | 1 | 2019 | 38 | 0.630 |
Why?
|
| Mean Platelet Volume | 1 | 2018 | 1 | 0.610 |
Why?
|
| Diabetic Nephropathies | 1 | 2018 | 17 | 0.600 |
Why?
|
| Lymphocytes | 1 | 2018 | 59 | 0.590 |
Why?
|
| Circle of Willis | 1 | 2017 | 5 | 0.540 |
Why?
|
| Sclerosis | 1 | 2017 | 57 | 0.530 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 30 | 0.530 |
Why?
|
| Temporal Lobe | 1 | 2017 | 77 | 0.520 |
Why?
|
| Thalamus | 4 | 2021 | 15 | 0.490 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 91 | 0.490 |
Why?
|
| Middle Aged | 22 | 2021 | 8653 | 0.480 |
Why?
|
| Adult | 22 | 2021 | 7658 | 0.480 |
Why?
|
| Humans | 43 | 2022 | 25950 | 0.480 |
Why?
|
| Image Enhancement | 2 | 2020 | 46 | 0.470 |
Why?
|
| Female | 27 | 2021 | 14422 | 0.470 |
Why?
|
| Male | 27 | 2021 | 14087 | 0.440 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 59 | 0.430 |
Why?
|
| Brain | 6 | 2021 | 1422 | 0.430 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 61 | 0.380 |
Why?
|
| Diagnostic Imaging | 2 | 2020 | 80 | 0.360 |
Why?
|
| Aged | 14 | 2021 | 8480 | 0.330 |
Why?
|
| Brain Ischemia | 2 | 2021 | 60 | 0.330 |
Why?
|
| Evoked Potentials, Motor | 1 | 2009 | 10 | 0.310 |
Why?
|
| Motor Cortex | 1 | 2009 | 17 | 0.310 |
Why?
|
| Brain Diseases | 1 | 2009 | 56 | 0.300 |
Why?
|
| Young Adult | 6 | 2021 | 1984 | 0.300 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 110 | 0.300 |
Why?
|
| Graft Rejection | 2 | 2018 | 68 | 0.270 |
Why?
|
| Contrast Media | 3 | 2020 | 62 | 0.270 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 820 | 0.260 |
Why?
|
| Liver Transplantation | 2 | 2018 | 91 | 0.260 |
Why?
|
| Auditory Cortex | 1 | 2005 | 3 | 0.250 |
Why?
|
| Case-Control Studies | 4 | 2021 | 550 | 0.240 |
Why?
|
| Risk Factors | 7 | 2021 | 2183 | 0.240 |
Why?
|
| Language | 1 | 2005 | 61 | 0.230 |
Why?
|
| Sex Characteristics | 1 | 2005 | 102 | 0.230 |
Why?
|
| Postoperative Complications | 3 | 2020 | 894 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 87 | 0.210 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 31 | 0.200 |
Why?
|
| Turkey | 2 | 2018 | 6 | 0.190 |
Why?
|
| Radiology | 1 | 2021 | 15 | 0.180 |
Why?
|
| Patient Care Planning | 1 | 2001 | 37 | 0.180 |
Why?
|
| Encephalocele | 1 | 2021 | 24 | 0.180 |
Why?
|
| Retrospective Studies | 9 | 2021 | 3469 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 46 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 83 | 0.180 |
Why?
|
| Antiviral Agents | 1 | 2021 | 71 | 0.170 |
Why?
|
| Glioma | 1 | 2021 | 19 | 0.170 |
Why?
|
| Adenolymphoma | 1 | 2020 | 4 | 0.170 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 6 | 0.170 |
Why?
|
| Nerve Net | 1 | 2021 | 38 | 0.170 |
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 46 | 0.170 |
Why?
|
| Facial Nerve | 1 | 2020 | 13 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 77 | 0.170 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2020 | 17 | 0.170 |
Why?
|
| Parotid Gland | 1 | 2020 | 17 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2020 | 29 | 0.170 |
Why?
|
| Dissection | 1 | 2020 | 25 | 0.170 |
Why?
|
| Parotid Neoplasms | 1 | 2020 | 14 | 0.170 |
Why?
|
| Gray Matter | 1 | 2021 | 47 | 0.170 |
Why?
|
| Hospital Mortality | 1 | 2021 | 128 | 0.170 |
Why?
|
| Kidney | 1 | 2001 | 149 | 0.170 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 7 | 0.170 |
Why?
|
| Artifacts | 1 | 2020 | 30 | 0.170 |
Why?
|
| White Matter | 2 | 2019 | 124 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 93 | 0.160 |
Why?
|
| Fasting | 1 | 2019 | 18 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 142 | 0.160 |
Why?
|
| Brain Edema | 1 | 2019 | 15 | 0.160 |
Why?
|
| Hernia | 1 | 2019 | 8 | 0.160 |
Why?
|
| Acute Disease | 2 | 2019 | 175 | 0.160 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 102 | 0.160 |
Why?
|
| Movement | 1 | 2020 | 104 | 0.160 |
Why?
|
| Neuroma, Acoustic | 1 | 2019 | 10 | 0.160 |
Why?
|
| Emergencies | 1 | 2019 | 30 | 0.160 |
Why?
|
| Sarcoidosis | 1 | 2019 | 14 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 17 | 0.160 |
Why?
|
| Spinal Cord Diseases | 1 | 2019 | 30 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 6 | 0.150 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 8 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2020 | 302 | 0.150 |
Why?
|
| Stomach | 1 | 2018 | 14 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 26 | 0.150 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 18 | 0.150 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 32 | 0.150 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 19 | 0.150 |
Why?
|
| Adiposity | 1 | 2019 | 43 | 0.150 |
Why?
|
| Weight Gain | 1 | 2019 | 61 | 0.150 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 38 | 0.150 |
Why?
|
| Brain Abscess | 1 | 2018 | 5 | 0.150 |
Why?
|
| Adolescent | 4 | 2020 | 2123 | 0.150 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 10 | 0.150 |
Why?
|
| Intracranial Pressure | 1 | 2018 | 13 | 0.150 |
Why?
|
| Spinal Diseases | 1 | 2019 | 93 | 0.150 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 41 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 108 | 0.140 |
Why?
|
| Child Development | 1 | 2019 | 67 | 0.140 |
Why?
|
| Nerve Fibers | 1 | 2018 | 11 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2018 | 72 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 25 | 0.140 |
Why?
|
| Pregnancy | 1 | 2019 | 321 | 0.140 |
Why?
|
| Erythrocyte Indices | 1 | 2017 | 5 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 161 | 0.140 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 9 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 213 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 644 | 0.140 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2017 | 3 | 0.140 |
Why?
|
| Biliary Tract | 1 | 2017 | 7 | 0.140 |
Why?
|
| Cysts | 1 | 2017 | 12 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 11 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 28 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 31 | 0.140 |
Why?
|
| Calcinosis | 1 | 2017 | 44 | 0.130 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 204 | 0.130 |
Why?
|
| Epithalamus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Afferent Pathways | 1 | 2016 | 4 | 0.130 |
Why?
|
| Functional Laterality | 1 | 2017 | 62 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2022 | 471 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 269 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 197 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2021 | 1686 | 0.130 |
Why?
|
| Stroke | 1 | 2018 | 236 | 0.120 |
Why?
|
| Child | 3 | 2021 | 1229 | 0.120 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 46 | 0.120 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 16 | 0.110 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 4409 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2020 | 413 | 0.110 |
Why?
|
| Corpus Callosum | 2 | 2019 | 10 | 0.110 |
Why?
|
| Parkinson Disease | 2 | 2018 | 618 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2006 | 194 | 0.100 |
Why?
|
| Prognosis | 3 | 2020 | 785 | 0.090 |
Why?
|
| Time Factors | 3 | 2020 | 1387 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1389 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1717 | 0.080 |
Why?
|
| Dementia, Vascular | 1 | 2010 | 38 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 463 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 340 | 0.080 |
Why?
|
| Neuroradiography | 1 | 2009 | 2 | 0.080 |
Why?
|
| Pediatrics | 1 | 2009 | 37 | 0.080 |
Why?
|
| Subclavian Artery | 1 | 2008 | 3 | 0.080 |
Why?
|
| Vertebral Artery | 1 | 2008 | 3 | 0.080 |
Why?
|
| Reference Values | 1 | 2009 | 175 | 0.070 |
Why?
|
| Hospitalization | 2 | 2021 | 294 | 0.070 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 4 | 0.070 |
Why?
|
| Thallium Radioisotopes | 3 | 1999 | 5 | 0.070 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 1999 | 10 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 393 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2021 | 596 | 0.070 |
Why?
|
| Graft Survival | 2 | 2018 | 96 | 0.070 |
Why?
|
| Organotechnetium Compounds | 3 | 1999 | 7 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 650 | 0.070 |
Why?
|
| Survival Rate | 2 | 2018 | 339 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2019 | 433 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2006 | 62 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1269 | 0.060 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2003 | 13 | 0.050 |
Why?
|
| Frontal Sinus | 1 | 2003 | 13 | 0.050 |
Why?
|
| Aphasia, Broca | 1 | 2003 | 2 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 8 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 14 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2003 | 15 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 69 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 603 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 47 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 3422 | 0.050 |
Why?
|
| Blindness | 1 | 2022 | 8 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2001 | 5 | 0.050 |
Why?
|
| Renal Artery | 1 | 2001 | 8 | 0.050 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 3 | 0.050 |
Why?
|
| Petrous Bone | 1 | 2021 | 5 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 438 | 0.050 |
Why?
|
| Pelvis | 1 | 2001 | 29 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 26 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2020 | 37 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 2019 | 10 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 11 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 39 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 430 | 0.040 |
Why?
|
| Spine | 1 | 2020 | 102 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1999 | 40 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1999 | 6 | 0.040 |
Why?
|
| Tennessee | 1 | 2018 | 5 | 0.040 |
Why?
|
| Ileum | 1 | 2018 | 14 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1998 | 11 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 136 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 1998 | 20 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 7 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 18 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 64 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 139 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 32 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 85 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 54 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2017 | 19 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 120 | 0.030 |
Why?
|
| Smoking | 1 | 2018 | 172 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2018 | 117 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 506 | 0.030 |
Why?
|
| Mothers | 1 | 2019 | 158 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 554 | 0.030 |
Why?
|
| Habenula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 313 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 38 | 0.030 |
Why?
|
| Succimer | 1 | 1995 | 1 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 2 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 9 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 265 | 0.030 |
Why?
|
| Thymoma | 1 | 1995 | 7 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1995 | 12 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1995 | 11 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 8 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 376 | 0.030 |
Why?
|
| Sugar Acids | 1 | 1994 | 1 | 0.030 |
Why?
|
| Behcet Syndrome | 1 | 1994 | 4 | 0.030 |
Why?
|
| Uveitis | 1 | 1994 | 10 | 0.030 |
Why?
|
| United States | 1 | 2019 | 1935 | 0.030 |
Why?
|
| Arteritis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Aneurysm | 1 | 2008 | 10 | 0.020 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
|
| Medical Illustration | 1 | 2006 | 12 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 54 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 168 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 319 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 5 | 0.010 |
Why?
|
| Calcitonin | 1 | 1999 | 14 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 2 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Neostigmine | 1 | 1998 | 4 | 0.010 |
Why?
|
| Peristalsis | 1 | 1998 | 12 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 54 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 91 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1999 | 54 | 0.010 |
Why?
|
| Morphine | 1 | 1998 | 72 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 129 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 205 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 624 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 5 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 31 | 0.010 |
Why?
|
| Adenoma | 1 | 1995 | 64 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 226 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 546 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 3575 | 0.010 |
Why?
|